CytoSorbents Corporation (CTSO)

[biotech48]

The earnings for Q2 2019 were very good, with record revenue and with very good guidance. In a normal market, the share price would have increased. There is no way that it should have dropped 14%. The only reason was shorts, you could see it building here on IHUB and the yahoo board also as posters wrote of impending doom, of not meeting expectations, attacking Dr. Chan and other management, going to $3 etc. There is nothing wrong with the company, it is basically on track with their plans, revenue is increasing. I believe that without the shorts, we would easily be at $15, doubling within a year and doubling again in 2021. Eventually the shorts will be overwhelmed, just a matter of when. One poster wrote of Cases of the Week being stubbed toes, most of the cases that I have read, have saved lives or limbs of patients. As pearsby famously called them, Miracle Beads. Probably the only true thing he ever posted.